imvaria empowers clinicians to improve patient outcomes through the development and application of modern computer science techniques to complex and serious diseases. The company's Digital Biomarker Platform enables non-invasive diagnostic and therapeutic patient stratification via data science and machine learning. imvaria's lead work is assigned FDA's Breakthrough Device Designation.